Venmax Drugs & Pharmaceuticals Ltd. reported audited earnings results for the fourth quarter and full year ended March 31, 2018. For the quarter, loss before exceptional items and tax of INR 1.736 million compared to INR 0.221 million a year ago. Loss before tax was INR 1.736 million compared to INR 0.221 million a year ago. Loss after tax was INR 1.736 million compared to INR 0.221 million a year ago. Basic and diluted LPS (not annualized) was INR 0.33 compared to INR 0.04 a year ago. For the year, loss before exceptional items and tax of INR 2.422 million compared to INR 4.911 million a year ago. Loss before tax was INR 2.422 million compared to INR 13.359 million a year ago. Loss after tax was INR 2.422 million compared to INR 13.359 million a year ago. Basic and diluted LPS (not annualized) was INR 0.46 compared to INR 2.55 a year ago.